Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Vascular and Endovascular Surgery
|
December 30, 2025
Long Term Outcomes of TEVAR for Blunt Thoracic Aortic Injury
Mohineesh Kumar, Mackenzie Madison, Tara Zielke, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 25, 2010
The Bentall procedure: is it the gold standard? A series of 597 consecutive cases
Christian D Etz, Moritz S Bischoff, Carol Bodian, et al.
European Journal of Pharmacology
|
May 7, 2022
Dequalinium chloride is an antagonists of α7 nicotinic acetylcholine receptors
Matthieu G Belanger-Coast, Mei Zhang, Vladislav Bugay, et al.
The Annals of Thoracic Surgery
|
November 25, 2010
When to operate on the bicuspid valve patient with a modestly dilated ascending aorta
Christian D Etz, Stefano Zoli, Robert Brenner, et al.
Frontiers in Physiology
|
October 11, 2013
Functional effects of KCNQ K(+) channels in airway smooth muscle
Alexey I Evseev, Iurii Semenov, Crystal R Archer, et al.
The Lancet. Neurology
|
July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor, Julian Furby, Thomas Hayton, et al.
Nature Biomedical Engineering
|
April 6, 2019
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
Bumwhee Lee, Kunwoo Lee, Shree Panda, et al.
Plos One
|
November 18, 2017
Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity
Luke E Whitmire, Ling Ling, Vladslav Bugay, et al.
Frontiers in Pharmacology
|
October 12, 2020
Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors
Vladislav Bugay, Derek J Wallace, Bin Wang, et al.
Plos One
|
August 13, 2013
Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression
Sharmilee Gnanapavan, Donna Grant, Steve Morant, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Vascular and Endovascular Surgery
|
December 30, 2025
Long Term Outcomes of TEVAR for Blunt Thoracic Aortic Injury
Mohineesh Kumar, Mackenzie Madison, Tara Zielke, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 25, 2010
The Bentall procedure: is it the gold standard? A series of 597 consecutive cases
Christian D Etz, Moritz S Bischoff, Carol Bodian, et al.
European Journal of Pharmacology
|
May 7, 2022
Dequalinium chloride is an antagonists of α7 nicotinic acetylcholine receptors
Matthieu G Belanger-Coast, Mei Zhang, Vladislav Bugay, et al.
The Annals of Thoracic Surgery
|
November 25, 2010
When to operate on the bicuspid valve patient with a modestly dilated ascending aorta
Christian D Etz, Stefano Zoli, Robert Brenner, et al.
Frontiers in Physiology
|
October 11, 2013
Functional effects of KCNQ K(+) channels in airway smooth muscle
Alexey I Evseev, Iurii Semenov, Crystal R Archer, et al.
The Lancet. Neurology
|
July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor, Julian Furby, Thomas Hayton, et al.
Nature Biomedical Engineering
|
April 6, 2019
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
Bumwhee Lee, Kunwoo Lee, Shree Panda, et al.
Plos One
|
November 18, 2017
Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity
Luke E Whitmire, Ling Ling, Vladslav Bugay, et al.
Frontiers in Pharmacology
|
October 12, 2020
Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors
Vladislav Bugay, Derek J Wallace, Bin Wang, et al.
Plos One
|
August 13, 2013
Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression
Sharmilee Gnanapavan, Donna Grant, Steve Morant, et al.
Page
of 5